KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $187.1 million.

  • Encompass Health's Capital Expenditures rose 2684.75% to $187.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $705.8 million, marking a year-over-year increase of 767.35%. This contributed to the annual value of $642.5 million for FY2024, which is 1018.69% up from last year.
  • According to the latest figures from Q3 2025, Encompass Health's Capital Expenditures is $187.1 million, which was up 2684.75% from $156.9 million recorded in Q2 2025.
  • Encompass Health's Capital Expenditures' 5-year high stood at $213.4 million during Q4 2021, with a 5-year trough of $98.8 million in Q1 2021.
  • For the 5-year period, Encompass Health's Capital Expenditures averaged around $150.7 million, with its median value being $149.3 million (2022).
  • As far as peak fluctuations go, Encompass Health's Capital Expenditures soared by 5622.25% in 2021, and later plummeted by 1160.32% in 2023.
  • Quarter analysis of 5 years shows Encompass Health's Capital Expenditures stood at $213.4 million in 2021, then decreased by 1.97% to $209.2 million in 2022, then grew by 1.2% to $211.7 million in 2023, then decreased by 6.14% to $198.7 million in 2024, then decreased by 5.84% to $187.1 million in 2025.
  • Its Capital Expenditures stands at $187.1 million for Q3 2025, versus $156.9 million for Q2 2025 and $163.1 million for Q1 2025.